Sala M, Chen C, Zhang Q, Do Umehara H, Wu W, Misharin A, et al. JNK2 up-regulates hypoxia-inducible factors and contributes to hypoxia-induced erythropoiesis and pulmonary hypertension. J Biol Chem. 2018;293:271-284 pubmed publisher

Fadhillah -, Yoshioka S, Nishimura R, Yamamoto Y, Kimura K, Okuda K. Hypoxia-inducible factor 1 mediates hypoxia-enhanced synthesis of progesterone during luteinization of granulosa cells. J Reprod Dev. 2017;63:75-85 pubmed publisher

Lim C, Nogawa T, Uramoto M, Okano A, Hongo Y, Nakamura T, et al. RK-1355A and B, novel quinomycin derivatives isolated from a microbial metabolites fraction library based on NPPlot screening. J Antibiot (Tokyo). 2014;67:323-9 pubmed publisher

Yonekura S, Itoh M, Okuhashi Y, Takahashi Y, Ono A, Nara N, et al. Effects of the HIF1 inhibitor, echinomycin, on growth and NOTCH signalling in leukaemia cells. Anticancer Res. 2013;33:3099-103 pubmed

Sato M, Nakazawa T, Tsunematsu Y, Hotta K, Watanabe K. Echinomycin biosynthesis. Curr Opin Chem Biol. 2013;17:537-45 pubmed publisher

Egger M, Huang J, Yin W, McMasters K, McNally L. Inhibition of autophagy with chloroquine is effective in melanoma. J Surg Res. 2013;184:274-81 pubmed publisher

Zhang C, Kong L, Liu Q, Lei X, Zhu T, Yin J, et al. In vitro characterization of echinomycin biosynthesis: formation and hydroxylation of L-tryptophanyl-S-enzyme and oxidation of (2S,3S) ?-hydroxytryptophan. PLoS ONE. 2013;8:e56772 pubmed publisher

Zimmermann S, Würgler Hauri C, Wanner G, Simmen H, Werner C. Echinomycin in the prevention of heterotopic ossification - an experimental antibiotic agent shows promising results in a murine model. Injury. 2013;44:570-5 pubmed publisher

Zhang J, Zhang Z, Wu Y, Chen L, Luo Q, Chen J, et al. Regulatory effect of hypoxia-inducible factor-1α on hCG-stimulated endothelin-2 expression in granulosa cells from the PMSG-treated rat ovary. J Reprod Dev. 2012;58:678-84 pubmed

Wang Z, Zhang Z, Wu Y, Chen L, Luo Q, Zhang J, et al. Effects of echinomycin on endothelin-2 expression and ovulation in immature rats primed with gonadotropins. Exp Mol Med. 2012;44:615-21 pubmed publisher

Espinosa A, Socha A, Ryke E, Rowley D. Antiamoebic properties of the actinomycete metabolites echinomycin A and tirandamycin A. Parasitol Res. 2012;111:2473-7 pubmed publisher

Branitzki Heinemann K, Okumura C, Völlger L, Kawakami Y, Kawakami T, Naim H, et al. A novel role for the transcription factor HIF-1? in the formation of mast cell extracellular traps. Biochem J. 2012;446:159-63 pubmed publisher

Tsuzuki T, Okada H, Cho H, Tsuji S, Nishigaki A, Yasuda K, et al. Hypoxic stress simultaneously stimulates vascular endothelial growth factor via hypoxia-inducible factor-1? and inhibits stromal cell-derived factor-1 in human endometrial stromal cells. Hum Reprod. 2012;27:523-30 pubmed publisher

Milesi Hallé A, McCullough S, Hinson J, Kurten R, Lamps L, Brown A, et al. Echinomycin decreases induction of vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity in mice. Basic Clin Pharmacol Toxicol. 2012;110:327-34 pubmed publisher

Maybin J, Hirani N, Jabbour H, Critchley H. Novel roles for hypoxia and prostaglandin E2 in the regulation of IL-8 during endometrial repair. Am J Pathol. 2011;178:1245-56 pubmed publisher

Jarikote D, Li W, Jiang T, Eriksson L, Murphy P. Towards echinomycin mimetics by grafting quinoxaline residues on glycophane scaffolds. Bioorg Med Chem. 2011;19:826-35 pubmed publisher

Lim C, Qiao X, Reslan O, Xia Y, Raffetto J, Paleolog E, et al. Prolonged mechanical stretch is associated with upregulation of hypoxia-inducible factors and reduced contraction in rat inferior vena cava. J Vasc Surg. 2011;53:764-73 pubmed publisher

Hirose Y, Watanabe K, Minami A, Nakamura T, Oguri H, Oikawa H. Involvement of common intermediate 3-hydroxy-L-kynurenine in chromophore biosynthesis of quinomycin family antibiotics. J Antibiot (Tokyo). 2011;64:117-22 pubmed publisher

Krishna O, Jeon O, Kim K, Byun Y, Moon H. Drug release from a chemically-anchored PEG/phospholipid monolayer onto polymer-coated metallic stents. J Biomater Sci Polym Ed. 2010;21:789-802 pubmed publisher

Regazzetti C, Bost F, Le Marchand Brustel Y, Tanti J, Giorgetti Peraldi S. Insulin induces REDD1 expression through hypoxia-inducible factor 1 activation in adipocytes. J Biol Chem. 2010;285:5157-64 pubmed publisher

Hu Y, Kirito K, Yoshida K, Mitsumori T, Nakajima K, Nozaki Y, et al. Inhibition of hypoxia-inducible factor-1 function enhances the sensitivity of multiple myeloma cells to melphalan. Mol Cancer Ther. 2009;8:2329-38 pubmed publisher

Watanabe K, Hotta K, Praseuth A, Searcey M, Wang C, Oguri H, et al. Rationally engineered total biosynthesis of a synthetic analogue of a natural quinomycin depsipeptide in Escherichia coli. Chembiochem. 2009;10:1965-8 pubmed publisher

Pfoh R, Cuesta Seijo J, Sheldrick G. Interaction of an echinomycin-DNA complex with manganese ions. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009;65:660-4 pubmed publisher

Watanabe K, Hotta K, Nakaya M, Praseuth A, Wang C, Inada D, et al. Escherichia coli allows efficient modular incorporation of newly isolated quinomycin biosynthetic enzyme into echinomycin biosynthetic pathway for rational design and synthesis of potent antibiotic unnatural natural product. J Am Chem Soc. 2009;131:9347-53 pubmed publisher

Kim J, Bagchi I, Bagchi M. Signaling by hypoxia-inducible factors is critical for ovulation in mice. Endocrinology. 2009;150:3392-400 pubmed publisher

Thangasamy A, Rogge J, Ammanamanchi S. Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells. J Biol Chem. 2009;284:14001-10 pubmed publisher

Watanabe K, Oguri H, Oikawa H. Diversification of echinomycin molecular structure by way of chemoenzymatic synthesis and heterologous expression of the engineered echinomycin biosynthetic pathway. Curr Opin Chem Biol. 2009;13:189-96 pubmed publisher

Foster B, Clagett Carr K, Shoemaker D, Suffness M, Plowman J, Trissel L, et al. Echinomycin: the first bifunctional intercalating agent in clinical trials. Invest New Drugs. 1985;3:403-10 pubmed

Gao X, Patel D. Antitumour drug-DNA interactions: NMR studies of echinomycin and chromomycin complexes. Q Rev Biophys. 1989;22:93-138 pubmed

Waring M. Echinomycin. Pathol Biol (Paris). 1992;40:1022-34 pubmed